PMID- 35271674 OWN - NLM STAT- MEDLINE DCOM- 20220503 LR - 20220531 IS - 1932-6203 (Electronic) IS - 1932-6203 (Linking) VI - 17 IP - 3 DP - 2022 TI - Psychosomatic syndromes are associated with IL-6 pro-inflammatory cytokine in heart failure patients. PG - e0265282 LID - 10.1371/journal.pone.0265282 [doi] LID - e0265282 AB - Psychosomatic syndromes have emerged as an important source of comorbidity in cardiac patients and have been associated with increased risk for adverse outcomes in patients with heart failure (HF). Understanding of the mechanisms underlying this connection is limited, however immune activity represents a possible pathway. While there have been numerous studies connecting immune activity to psychosomatic psychopathology, there is a lack of research on patients with HF. We examined forty-one consecutive outpatients affected by HF. We assessed psychosomatic psychopathology using the Diagnostic Criteria for Psychosomatic Research (DCPR) and the Patient Health Questionnaire-15 (PHQ-15). The Psychosocial Index (PSI) was used for assessing stress and psychosocial dimensions. Depression was evaluated with Beck Depression Inventory-II (BDI-II). Circulating levels of proinflammatory cytokines IL-6 and TNF-alpha were ascertained. Univariate and multivariable regression models were used to test for associations between inflammatory cytokines and psychosomatic psychopathology (i.e., DCPR syndromes, PHQ-15) and psychological dimensions (i.e., BDI-II, PSI). A significant positive correlation was found between IL-6 levels and psychosomatic psychopathology even when controlling for any confounding variables (i.e., Body-mass index (BMI), New York Heart Association (NYHA) class, smoking habits, alcohol consumption, statin use, aspirin use, beta blockers use, age, and gender). In contrast, the associations between TNF-alpha levels were non-significant. These findings can contribute to research in support of a psychoneuroimmune connection between psychosomatic psychopathology and HF. Findings also suggest the possibility that elevated IL-6 levels are more relevant for the pathogenesis of psychosomatic syndromes than for depression in patients with HF. FAU - Altamura, Mario AU - Altamura M AUID- ORCID: 0000-0002-5684-5403 AD - Department of Clinical and Experimental Medicine, University of Foggia, Foggia, Italy. FAU - D'Andrea, Giovanna AU - D'Andrea G AD - Department of Clinical and Experimental Medicine, University of Foggia, Foggia, Italy. FAU - Angelini, Eleonora AU - Angelini E AD - Department of Clinical and Experimental Medicine, University of Foggia, Foggia, Italy. FAU - Tortorelli, Fabio M P AU - Tortorelli FMP AD - Department of Clinical and Experimental Medicine, University of Foggia, Foggia, Italy. FAU - Balzotti, Angela AU - Balzotti A AD - Department of Clinical and Experimental Medicine, University of Foggia, Foggia, Italy. FAU - Porcelli, Piero AU - Porcelli P AUID- ORCID: 0000-0002-2263-8051 AD - Department of Psychological, Health and Territorial Sciences, D'Annunzio University of Chieti-Pescara, Chieti, Italy. FAU - Margaglione, Maurizio AU - Margaglione M AD - Department of Clinical and Experimental Medicine, University of Foggia, Foggia, Italy. FAU - Brunetti, Natale D AU - Brunetti ND AD - Department of Medical and Surgical Sciences, University of Foggia, Foggia, Italy. FAU - Cassano, Tommaso AU - Cassano T AD - Department of Medical and Surgical Sciences, University of Foggia, Foggia, Italy. FAU - Bellomo, Antonello AU - Bellomo A AD - Department of Clinical and Experimental Medicine, University of Foggia, Foggia, Italy. LA - eng PT - Journal Article DEP - 20220310 PL - United States TA - PLoS One JT - PloS one JID - 101285081 RN - 0 (Cytokines) RN - 0 (IL6 protein, human) RN - 0 (Interleukin-6) RN - 0 (Tumor Necrosis Factor-alpha) SB - IM MH - Cytokines MH - *Heart Failure MH - Humans MH - Interleukin-6/*blood MH - Psychophysiologic Disorders/psychology MH - Syndrome MH - Tumor Necrosis Factor-alpha PMC - PMC8912235 COIS- The authors have declared that no competing interests exist. EDAT- 2022/03/11 06:00 MHDA- 2022/05/04 06:00 PMCR- 2022/03/10 CRDT- 2022/03/10 17:14 PHST- 2021/11/03 00:00 [received] PHST- 2022/02/24 00:00 [accepted] PHST- 2022/03/10 17:14 [entrez] PHST- 2022/03/11 06:00 [pubmed] PHST- 2022/05/04 06:00 [medline] PHST- 2022/03/10 00:00 [pmc-release] AID - PONE-D-21-35033 [pii] AID - 10.1371/journal.pone.0265282 [doi] PST - epublish SO - PLoS One. 2022 Mar 10;17(3):e0265282. doi: 10.1371/journal.pone.0265282. eCollection 2022.